Q1 2024 Holdings
Filed 2024-05-15 | 91 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $208.8M | 2,200,000 | 15.5% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $59.7M | 259,749 | 4.4% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $53.1M | 7,227,353 | 3.9% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $51.9M | 3,505,000 | 3.9% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $49.2M | 3,486,440 | 3.7% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $48.2M | 3,168,456 | 3.6% |
| Celcuity Inc(CELC) | COM | 15102K100 | $37.4M | 1,731,338 | 2.8% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $34.9M | 1,187,096 | 2.6% |
| Neuropace Inc(NPCE) | COM | 641288105 | $32.1M | 2,433,168 | 2.4% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $30.5M | 3,589,558 | 2.3% |
| Organogenesis Hldgs Inc(ORGO) | COM | 68621F102 | $27.2M | 9,573,198 | 2.0% |
| Axogen Inc(AXGN) | COM | 05463X106 | $25.1M | 3,105,815 | 1.9% |
| Humana Inc(HUM) | COM | 444859102 | $25.0M | 72,006 | 1.9% |
| Surmodics Inc(SU6) | COM | 868873100 | $23.5M | 800,820 | 1.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $23.5M | 728,700 | 1.7% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $23.4M | 533,515 | 1.7% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $23.2M | 148,100 | 1.7% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $20.1M | 2,458,996 | 1.5% |
| Penumbra Inc(PEN) | COM | 70975L107 | $19.1M | 85,700 | 1.4% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $18.2M | 1,540,634 | 1.3% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $18.1M | 273,600 | 1.3% |
| Treace MED Concepts Inc(TMCI) | COM | 89455T109 | $17.6M | 1,345,648 | 1.3% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $17.2M | 51,441 | 1.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $16.4M | 1,115,000 | 1.2% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $16.1M | 725,457 | 1.2% |
| Iradimed Corp(IRMD) | COM | 46266A109 | $15.9M | 361,630 | 1.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $15.7M | 72,800 | 1.2% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $15.0M | 84,100 | 1.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $14.2M | 207,750 | 1.1% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $14.0M | 4,065,197 | 1.0% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $13.7M | 319,217 | 1.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $13.7M | 9,241,986 | 1.0% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $13.6M | 800,000 | 1.0% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $13.3M | 277,000 | 1.0% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $10.9M | 695,759 | 0.8% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $10.7M | 1,350,145 | 0.8% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $10.6M | 1,564,916 | 0.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $10.4M | 150,000 | 0.8% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $10.1M | 580,546 | 0.8% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $9.7M | 129,288 | 0.7% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $9.6M | 7,293,007 | 0.7% |
| CG Oncology Inc(CGON) | COM | 156944100 | $9.6M | 217,871 | 0.7% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $9.4M | 267,871 | 0.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $9.3M | 401,901 | 0.7% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $9.3M | 570,982 | 0.7% |
| Merus N V | COM | N5749R100 | $8.8M | 195,577 | 0.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.8M | 369,000 | 0.7% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $8.6M | 2,616,953 | 0.6% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $8.6M | 264,650 | 0.6% |
| Theratechnologies Inc(TQ80) | COM NEW | 88338H704 | $8.0M | 4,801,376 | 0.6% |